Fumihiro Takahashi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Prognostic Factors

Placebo Controlled

Amyotrophic Lateral Sclerosis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, Fumihiro Takahashi, Melissa Hagan, Stephen Apple
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis. Muscle & nerve (2023)
Fumihiro Takahashi, Osamu Kano, Yoshito Nagano, Takatomo Yoneoka, Sally Nelson, Yoshiteru Ushirogawa
Associations between the ALSFRS-R score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of ALSFRS-R scores in clinical studies MCI186-16, MCI186-17, and MCI186-19. Muscle & nerve 66 (5) (2022)
Fumihiro Takahashi, Osamu Kano, Yoshito Nagano, Takatomo Yoneoka, Sally Nelson, Yoshiteru Ushirogawa
Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies MCI186-16, MCI186-17, and MCI186-19. Muscle & nerve 66 (5) (2022)